M.A. Krymukova
YOU?
Author Swipe
View article: Phase II clinical trial of refralon tablets in patients with persistent atrial fibrillation and atrial flutter. The structure and plan of the study
Phase II clinical trial of refralon tablets in patients with persistent atrial fibrillation and atrial flutter. The structure and plan of the study Open
Refralon (cavutilide) is a highly effective drug for intravenous administration to restore sinus rhythm in patients with atrial fibrillation (AF) and atrial flutter (AFl) of any duration. Phase I clinical trial of tablets described pharmac…
View article: Refralon for drug-induced cardioversion of atrial fibrillation in patients with coronary artery disease
Refralon for drug-induced cardioversion of atrial fibrillation in patients with coronary artery disease Open
Atrial fibrillation (AF) is the leading cause of morbidity and hospitalizations among all cardiac arrhythmias. Moreover, the number of patients with coronary artery disease and other structural heart diseases leading to atrial remodeling i…
View article: Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter Open
Aim . To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibrillation and flutter (AF/AFL). Material and methods . Fifty five patients (mean age, 65±11 years)…